Navigation Links
Drug companies in India keen on developing bird flu drug

The government is likely to invoke the compulsory licensing (CL) provision in the Patents Act that would enable domestic drug //firms to produce and stockpile Swiss drug maker Roche’s patented drug Tamiflu, useful in combating the global threat against the most dreaded avian flu virus.

Section 92 empowers the government to issue CL without receipt of an application from the industry. Furthermore, the issue of such license is independent of third party consent. The following proposal is expected to help cope up with a public health emergency that might arise in case the pandemic hits India. Once compulsory licensing has been issued, manufacture of the drug can be initiated, to ensure both domestic and international supply.

The drug companies in India are more than willing to participate in the initiative. Ranbaxy Laboratories has already initiated talks with the Swiss pharma company regarding the issue. The company is also getting in touch with governments across the world, interested in sourcing the drug from it.

The situation would however require a critical analysis of patents issue across the world. It would be six months before the drug can actually be manufactured following regulatory approvals.

In response to the above situation, Roche has announced it would not welcome interventions by generic drug makers in Tamiflu market, the demand for which has increased manifold following reports that the pandemic has reached Europe and SE Asia.

Medindia on Bird Flu:

Avian influenza (AI) or Bird Flu is a disease of viral etiology that ranges from a mild or even asymptomatic infection to an acute, fatal disease of chickens, turkeys, guinea fowls, and other avian species, especially migratory waterfowl
'"/>




Page: 1

Related medicine news :

1. India to benefit from pharma companies move
2. Doctors not to accept gifts from drug companies
3. Pharmaceutical companies are targeting patients
4. Historic trial for tuberculosis launched together by leading drug companies
5. Pakistan drug companies seek trade ties with India
6. Depression Accompanies Heart Attacks in Younger Women
7. Cigarette companies adopt devious methods to ensure customer patronage
8. Is Diabetes the Leading Cause of Kidney Failure in India
9. AIDS Disaster in India is Imminent
10. Indian Prime Minister has successful Knee Replacement Surgery
11. International community warns India on HIV situation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... ... 22, 2017 , ... In a recent article ... context (age, illness and life choices) should be dissociated from medical errors and ... In addition, all too often, studies regarding health system performance in other countries, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... for supply chain management (SCM) and spend management, today announced that Keppel Corporation ... time, and simplify expense tracking. , “We are excited to announce the ...
(Date:2/21/2017)... ... February 22, 2017 , ... Author Michèle Wolff has ... for every household and family to know all about it for optimal health. Wanting ... the release of “ Detox, Digestive and Wellness Solutions ” (published by Balboa Press ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... five new hospital-grade power extension cords that meet the most current standards. , ... 2012 edition of the National Fire Protection Association (NFPA) 101 – Life Safety ...
(Date:2/21/2017)... CA (PRWEB) , ... February 21, 2017 , ... Doctors ... , CA, directed by Dr. Kendell Mendonca , to its growing network of ... compensation injuries including injuries stemming from car accidents such as whiplash, back pain, neck ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 22, 2017  Bioness, Inc., the leading provider of ... first series of successful StimRouter Neuromodulation System implantations in ... Center (Nijmegen, Netherlands ), ... ), and Kliniek Park Leopold Chirec ( ... Bioness plans to further support clinicians across the continent ...
(Date:2/22/2017)... PUNE, India , February 22, 2017 According ... (Spectroscopy, Chromatography), Measurement (On-Line, In-Line, At-Line), Products and Services (Analyzers, Probes & ... to 2021", published by MarketsandMarkets, the global market is poised to reach ... a CAGR of 13.3% from 2016 to 2021. ... ...
(Date:2/22/2017)... SEATTLE , Feb. 22, 2017 ... translational development of novel immune modulating therapies, today ... the a9a10 nicotinic acetylcholine receptor (nAChR), demonstrates robust ... preclinical pain models. The study also establishes the ... the treatment of chronic pain. The findings were ...
Breaking Medicine Technology: